alexander D.

kharlamov

JOHN

M.D., FESC, FACC, FEACVI

 

Physician, Cardiologist | Trialist | Innovator | Translational Researcher |

Heart Health Advocate and Volunteer | Messenger

Pioneer of Cardiovascular Nanomedicine

Clinical Cardiology: Non-Invasive, Interventional, Acute and Intensive Care | 

Imaging (MSCT/ CCTA, CMR, MPI, PET, TTE, QCA, IVUS, OCT, NIRS) |

Translational Cardiology: Arterial Remodeling/ Atherosclerosis | Biomedical Engineering, Coronary Devices |

Preventive Cardiology and Genetics | Regenerative Medicine and Longevity | Nanomedicine |

Sex- and Gender-Based Medicine | Public Health Management and Advocacy | 

Philosophy of Science: Consciousness, Immortality, Singularitarianism, Transhumanism | 

Civilizational Anti-Russian Sentiment

 

*** 

Scio quia omnia potes et nulla te latet cogitatio, Job 42:2

Potestas et timor apud eum est, qui facit concordiam in sublimibus suis, Job 25:2

Quia hæc dicit Excelsus, et Sublimis, habitans æternitatem, et sanctum nomen ejus, in excelso et in sancto habitans, et cum contrito et humili spiritu : ut vivificet spiritum humilium, et vivificet cor contritorum, Isaiah 57:15

ABOUT

ME!

 

Dr. J. A. D. Kharlamov has 24 years of the clinical experience in general cardiology (since 1996; a Consultant Physician since 2007, a Board-Certified Cardiologist since 2010), 19 years of the translational research in nanomedicine and biomedical engineering (since 2001), and about 13 years of the bench-to-bedside studies in interventional cardiology (a leader of the research group since 2007) including academic research in imaging, vascular biology, and pathology, RTD of cardiovascular imaging software (artificial intelligence/ machine learning), medical devices (bioresorbable scaffolds and stents, nanomedicine). He has moved to Russia in babyhood having American, Dutch and British roots, and has received his M.D. (Doctor of Medicine) cum laude in 2005 from Ural Medical University (Yekaterinburg, Russia). After finishing his internship in internal medicine in 2007 at the Ural Institute of Cardiology (mentor - Prof. Jan Gabinsky, Yekaterinburg, Russia) he started as a physician and translational researcher (a group leader as an Assistant Professor) in the field of interventional cardiology and nanobiotechnologies. The main research direction now is an RTD of the multifunctional nanoparticles for theranostics of atherosclerosis. He is an inventor of the revolutionary application which has the potential to replace conventional stenting and CABG. He has passed his C.Sc.-doctoral/ graduate degree course in cardiology (A.B.D.) at the Ural Medical University in 2008-2011. Since 2007-2009 he has been working as a research fellow in some institutes in the Netherlands (UMC St Radboud, Nijmegen; UMCG, Groningen; Erasmus MC, Rotterdam including mentorship of the renowned Prof. Patrick Serruys). He is an author of more than 60 articles and grant proposals for the European Commission and has received for his research work some national and international awards. Since Dec 2018 he is a FESC, and Jan 2019 - a FACC, Jan 2020 - a FEACVI.

Publications:
h-index = 9. The publication profile is available in ResearchGate, PubMed (akharlamov@orcid), ORCiD (0000-0003-4631-1261), ResearcherID (I-3692-2015), Russian Science Index (7738-9429), and Scopus (56721449700). The editorial/ reviewer profile (Local editorial board member in EuroIntervention in 2011-2013, member of the International Editorial Board in European Heart Journal in 2013-2015, consulting editor in both Cardiovascular Diagnosis and Therapy in 2013-2017, and International Journal of Nanomedicine in 2013-2019), member of the Editorial Board in World Journal of Cardiology (since 2018) is available in Publons (publons.com/a/1136995/).

Memberships:
European Society of Cardiology - ESC (since 2006; FESC since 2018; FEACVI since 2020), American College of Cardiology - ACC (since 2009; FACC since 2019), American Heart Association - AHA (since 2009), International Society for Stem Cell Research - ISSCR (since 2009), International Society of Nephrology - ISN (since 2009), European Society for Nanomedicine - ESNM (since 2011), The Society for Cardiovascular Angiography and Interventions - SCAI (since 2017), World Sleep Society - WSS (since 2018), The British Society for Nanomedicine - BSN (since 2018), Royal College of Physicians of London - RCP (since 2019), International Society for Cardiovascular Translational Research - ISCTR (since 2019), American Association for the Advancement of Science - AAAS (since 2019), Society of Cardiovascular Computed Tomography - SCCT (since 2019).

  • LinkedIn Social Icon
  • Google Scholar
  • NCBI
  • Scopus
  • Publons
  • ResearchGate
  • ORCiD
  • liveplan-logo_edited

Lifetime Achievements

LOGO_edited.jpg

De Haar Research Task Force (DHRF, DHRF Pro)

Registered with CoC/ KvK: 75124408

VAT/ BTW: NL002515719B51

The structure of the DHRF includes three labs:
1) Translational Research Lab for Biomedical Engineering and Cardiovascular Nanomedicine (DHRF Cramer Lab) with a focus on translational research and RTD in biomedical engineering (including the artificial womb), nanomedicine, medical devices (multifunctional bioresorbable scaffolds), and regression of atherosclerosis
2) Advanced Cardiovascular Imaging CoreLab (DHRF Da Vinci Lab) is a CoreLab with the expert analysis of both invasive and non-invasive (interventional/ intravascular) techniques in cardiology including the development of the artificial intelligence-based imaging software
3) Trialist Lab (DHRF Van Buren Lab) is essentially an assistant and management research service to the clinical trials in general and interventional cardiology

 
 

Please, Support our Task Force and Research Initiative!

All together we can revolutionize cardiology and save millions of lives!

Mapping Twitter followers

Mapping visitors

Visitor counter

Social and Scientific Networking

Analytics of Followers

 GET IN ToUCH! 

CONTACT

US

FOR ANY CORRESPONDENCE:

DHRF

Keurenplein 41

Box G9950

1069CD Amsterdam

The Netherlands

HIGH VALUE PARCEL DELIVERY IS FEASIBLE BY REQUEST via SKYBOX SERVICE with a post address either in the U.S. (Doral, FL) or U.K. (Hounslow, Middlesex)

​​

Fax: +31-87-7842273​

akharlamov@dhrfpro.com

  • White LinkedIn Icon
  • White Facebook Icon
  • White Twitter Icon
  • White Instagram Icon

VISIT

US

VISITORS STRICTLY BY APPOINTMENT ONLY 24/7 

DHRF
Dr Alexander Kharlamov
Strevelsweg 700
T.a.v. Unit 303-G9950
3083AS Rotterdam

The Netherlands

TELL

US

© 2023 by Actor & Model. Proudly created with Wix.com

Marie Curie Actions Awardee 2013